Interval detected breast cancers are more often basal‐like and HER2 positive [41] and demonstrate a stiffer collagen stroma and higher immune cell infiltration [42] in contrast to screen‐detected tumors. The gene discussed is ERBB2; the disease is breast carcinoma.